Astrazeneca Plc ADR (AZN)

$78.58 0.05 (0.06%)

16:00 EDT AZN Stock Quote Delayed 30 Minutes

7 Stocks to Buy When There’s Blood in the Streets

By Faisal Humayun, InvestorPlace Contributor Oct 18, 2022

For investors looking for high-quality stocks to buy when there is blood in the streets, there happen to be plenty of companies to pick.

7 Large-Cap Stocks With Sustained Dividend Growth Potential

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’

7 Large-Cap Stocks With Sustained Dividend Growth Potential

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 2.61M

Day's Range $78.32 - $79.26

52-Week Range $60.47 - $87.68

Dividend & Yield $0.93 (1.18%)

AZN Stock Predictions, Articles, and Astrazeneca Plc ADR News

7 Blue-Chip Stocks to Buy and Hold for the Long-Haul

By Faisal Humayun, InvestorPlace Contributor Jun 22, 2022

Amid interest hikes and general market volatility, we've picked seven blue-chip stocks to buy and hold for long-term value creation through dividends and stock upside.

5 Stocks to Buy for the Coming Recession

By Faisal Humayun, InvestorPlace Contributor May 18, 2022

Each of these stocks to buy are low-beta stocks with attractive dividend yields to help endure a recession.

7 Desirable Dividend Growth Stocks for Income Investors

By Faisal Humayun, InvestorPlace Contributor Apr 8, 2022

Dividend growth stocks that are worth considering for the long-term for income investors. Low-beta stocks at an attractive valuation.

3 Vaccine Stocks to Buy on the New Covid Variant Surge

By Faisal Humayun, InvestorPlace Contributor Mar 31, 2022

These vaccine stocks are likely to trend higher with the recent surge in covid-19 cases and concerns related to a new variant.

Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead

By William White, InvestorPlace Writer Mar 10, 2022

We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.

4 Pharma Stocks to Buy Even if the Pandemic Ends

By Faisal Humayun, InvestorPlace Contributor Feb 24, 2022

Here are four pharma stocks that looks attractive for the long-term. Deep product development pipelines will ensure steady revenue and cash flow growth.

7 Safe Stocks to Buy If You Fear the Bear

By Tezcan Gecgil, InvestorPlace Contributor Feb 23, 2022

Safe stocks tend to perform well no matter what the broader market does. Here are seven defensive companies to research further.

4 Great Global Stocks to Buy for a Diversified Portfolio

By Faisal Humayun, InvestorPlace Contributor Feb 3, 2022

Global stocks that are worth holding for the long-term for a well diversified portfolio. High growth global stocks with strong fundamentals.

7 Bear Market Stocks to Buy If You See Trouble Ahead

By Faisal Humayun, InvestorPlace Contributor Jan 20, 2022

These bear market stocks provide capital protection in a sharp correction scenario. They also typically have a healthy dividend yield.

BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today

By William White, InvestorPlace Writer Dec 22, 2021

There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor Nov 30, 2021

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

7 Foreign Stocks All U.S. Investors Should Be Watching

By Chris MacDonald, InvestorPlace Contributor Oct 13, 2021

U.S. investors looking to diversify their portfolio to maximize long-term returns may want to consider these top foreign stocks right now.

4 Stocks to Buy for Protection From an Evergrande-Driven Correction

By Faisal Humayun, InvestorPlace Contributor Sep 23, 2021

With markets jittery due to a potential crisis in China, here are four low beta stocks to buy for portfolio protection and dividends.

7 Best Robinhood Stocks to Buy for September

By Faisal Humayun, InvestorPlace Contributor Aug 26, 2021

Consider locking down these Robinhood stocks before there's another lockdown or market correction in the month of September.

4 Underperforming Stocks Positioned for a Strong Reversal

By Faisal Humayun, InvestorPlace Contributor Aug 18, 2021

Here are four underperforming stocks that look good for a strong reversal on positive fundamental developments.

4 Low Beta Stocks to Protect Your Portfolio Against Any Correction

By Faisal Humayun, InvestorPlace Contributor Jul 29, 2021

Low-beta stocks can protect a portfolio from a market correction. These four stocks have low volatility and high dividend yields.

MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500

By William White, InvestorPlace Writer Jul 16, 2021

Moderna (MRNA) stock is on the rise Friday as the company prepares to join the S&P 500 next week replacing Alexion Pharmaceuticals (ALXN).

7 Dividend Stocks Offering Juicy Yields and Short-Squeeze Potential

By Tezcan Gecgil, InvestorPlace Contributor Jun 14, 2021

Shares don't always rise, but dividend income is as steady as it gets. These dividend stocks are great long-term, despite recent weaknesses.

7 Beaten-Down Stocks to Buy Right Now for a June Rebound

By Tezcan Gecgil, InvestorPlace Contributor Jun 7, 2021

Are you looking for stocks that have been beaten up in recent weeks? Here are seven stocks to buy right now at the start of the summer.

VACC Stock IPO: 7 Things to Know as Vaccitech Starts Trading Today

By Chris MacDonald, InvestorPlace Contributor Apr 30, 2021

Here's how VACC stock has performed thus far following the company's highly anticipated IPO in the market today.

Astrazeneca Plc ADR (AZN)

7 Stocks to Buy When There’s Blood in the Streets

7 Large-Cap Stocks With Sustained Dividend Growth Potential

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’

7 Large-Cap Stocks With Sustained Dividend Growth Potential

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Astrazeneca Plc ADR (AZN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AZN Stock Predictions, Articles, and Astrazeneca Plc ADR News

Subscriber Sign in